posted on 2020-12-01, 00:00authored byJames J Hopkins
Herpes simplex virus 2 (HSV-2) can productively infect many different cell types of human and
nonhuman origin. Nucleoside analogs such as acyclovir (ACV) are currently prescribed
clinically to curb this infection. Here we demonstrate interconnected roles for host enzymes,
heparanase (HPSE), heparanase 2 (HPSE 2) and cathepsin L (Cath L), in HSV-2 release and
inhibition in cells. In vaginal epithelial cells, HSV-2 causes heparan sulfate shedding and
upregulation in HPSE, HPSE 2 and, Cath L protein levels during the productive phase of
infection. Furthermore, inhibition of HPSE dramatically reduces HSV-2 release from vaginal
epithelial cells, while HPSE 2 inhibition also show markedly less infection. Overexpression of
HPSE leads to an increase in viral progeny, interestingly overexpression of HPSE 2 leads to less
virus production. This work proposes that the HPSE increase after infection is mediated by an
increased NF-_B nuclear localization and a resultant activation of HPSE transcription. Together
these mechanisms contribute to the removal of heparan sulfate from the cell surface and thus
facilitate virus release from cells. For HPSE 2 it’s proposed that the increase after infection is a
response to the clearing of HS that can lead to some inhibition of infection, though more work is
needed on this. Finally, also studied was a small molecule inhibitor, BX795, as a new and
alternative solution to reduce HSV burden in humans. This work reported evidence for strong
antiviral efficacy of BX795 on HSV-2 infection in vaginal epithelial cells in vitro at 10 µM and
in vivo at 50 µM. Additionally, through biochemical assays in vitro and histopathology in vivo,
it was showed that the tolerability of BX795 in vaginal epithelial cells at concentrations as high
as 80 µM. Finally, using a murine model of vaginal infection, it was shown that topical therapy
using 50 µM BX795 is well tolerated and efficacious in controlling HSV-2 replication.
History
Advisor
Shukla, Deepak
Chair
Shukla, Deepak
Department
Microbiology and Immunology
Degree Grantor
University of Illinois at Chicago
Degree Level
Doctoral
Degree name
PhD, Doctor of Philosophy
Committee Member
Freitage, Nancy
McLachlan, Alan
Minshall, Richard
Valyi-Nagy, Tibor